Publication at Third Faculty of Medicine |
2019
Abstract
Atopic dermatitis is a chronic inflammatory skin disease affecting between 1 and 3 % of adult population. The incidence in children is even higher.
Due to significant itching, other subjective problems, and also the visibility of the lesions significantly reduces the quality of life. In localized forms, topical therapies are often sufficient, but systemic therapy is needed in generalized settings.
Here we describe the case of a patient with severe atopic dermatitis who has failed classical systemic therapy and is a suitable candidate for biologic treatment with dupilumab.